Carlyle Group Inc.
- SEC CIK
- 0001527166
- Latest filing
- Aug 7, 2026
JSPR holding history
Jasper Therapeutics, Inc. in every 13F filed by Carlyle Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JSPR overviewAll 13F holders of JSPRFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,066,189
- Value
- $448.9K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,066,189 | $448.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,066,189 | $934.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,066,189 | $1.94M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,066,189 | $2.53M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,066,189 | $5.92M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,066,189 | $4.58M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,066,189 | $22.7M | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,066,189 | $19.9M | 2.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,066,189 | $24.2M | 2.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,066,189 | $31.3M | 2.0% | −7,695,702−87.8% | Reduced | Holders |
| Q4 2023 | 8,761,891 | $6.67M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 8,761,891 | $6.05M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 8,761,891 | $11.8M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2023 | 8,761,891 | $15.8M | 0.5% | +8,761,891 | New | Holders |